Publicaciones en colaboración con investigadores/as de University of Amsterdam (20)

2024

  1. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 10, pp. 2648-2668.e2

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

2022

  1. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells

    International journal of molecular sciences, Vol. 23, Núm. 18

2021

  1. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676

  2. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2337-2353

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 5, pp. 855-873

2018

  1. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 816-826

  2. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 1, pp. 64-76

2016

  1. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Nature Genetics, Vol. 48, Núm. 9, pp. 1037-1042

2010

  1. Binding of CDR-derived peptides is mechanistically different from that of high-affinity parental antibodies

    Journal of Molecular Recognition, Vol. 23, Núm. 6, pp. 559-568

2009

  1. A Combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity

    Journal of Biological Chemistry, Vol. 284, Núm. 49, pp. 34126-34134

2008

  1. Affinity maturation of antibodies assisted by in silico modeling

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 26, pp. 9029-9034

  2. Designing antibodies for the inhibition of gastrin activity in tumoral cell lines

    International Journal of Cancer, Vol. 122, Núm. 10, pp. 2351-2359

2002

  1. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections

    Blood, Vol. 100, Núm. 3, pp. 1026-1030

2000

  1. A sensitive monoclonal antibody sandwich ELISA for the measurement of the major olive pollen allergen Ole e 1

    International Archives of Allergy and Immunology, Vol. 122, Núm. 3, pp. 224-228

  2. β(1,2)-xylose and α(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens

    Journal of Biological Chemistry, Vol. 275, Núm. 15, pp. 11451-11458

1997

  1. Studies on the intracellular localization of acetyl-CoA carboxylase

    Biochemical and Biophysical Research Communications, Vol. 233, Núm. 1, pp. 253-257